Company: EDSA
Filing Date: 2025-02-14
Form Type: SCHEDULE 13D/A
Source: 0001171843-25-000871
Chunk: 0

Company: Edesa Biotech, Inc.
Filing Date: 2025-02-14
Form: SCHEDULE 13D/A
Chunk 0
---
 Shares underlying vested share options and (d) 132,433 Common Shares underlying Series B-1 Preferred Shares that are beneficially owned and deemed outstanding with respect to this Reporting Person; and (ii) shared voting and dispositive power of 1,254,012 Common Shares, comprised of: (a) 341,702 Common Shares, an additional 16,305 Common Shares underlying vested warrants and 435,414 Common Shares underlying Series A-1 Preferred Shares that are deemed outstanding held by Pardeep Nijhawan Medicine Professional Corporation, (b) 32,013 Common Shares held by The Digestive Health Clinic Inc., (c) 53,104 Common Shares held by 1968160 Ontario Inc., and (d) 32,609 Common Shares and an additional 16,305 Common Shares underlying vested warrants that are deemed outstanding held by The New Nijhawan Family Trust 2015. Pardeep Nijhawan's holdings exclude 388,400 Common Shares underlying Series B-1 Preferred Shares held by Pardeep Nijhawan, which are subject to a 19.99% beneficial ownership blocker as described in Item 3. Pardeep Nijhawan's holdings represent an aggregate of approximately 19.99% of the Issuer's outstanding Common Shares (based on a total of 6,936,404 Common Shares of the Issuer outstanding as of February 14, 2025, an additional 49,728 Common Shares underlying vested share options, an additional 75,435 Common Shares underlying vested restricted share units, an additional 359,170 Common Shares underlying vested warrants, 435,414 Common Shares underlying Series A-1 Preferred Shares and 132,433 Common Shares underlying Series B-1 Preferred Shares that are beneficially owned and deemed outstanding with respect to this Reporting Person). 
 As of the date hereof, Pardeep Nijhawan Medicine Professional Corporation may be deemed to be the beneficial owner, with shared voting and dispositive power, of an aggregate of 1,119,981 Common Shares, comprised of: (i) 341,702 Common Shares, (ii) 342,865 Common Shares underlying vested warrants and (iii) 435,414 Common Shares underlying Series A-1 Preferred Shares that are deemed outstanding with respect to this Reporting Person. Pardeep Nijhawan Medicine Professional Corporation's holdings represent an aggregate of approximately 14.5% of the Issuer's outstanding Common Shares (based on a total of 6,